PerkinElmer is a global leader focused on improving the health and safety of people and the environment.
Business Model:
Revenue: $0
Employees: 10,001-1
Address:
City: Waltham
State: Massachusetts
Zip:
Country: United States
PerkinElmer is a global leader focused on improving the health and safety of people and the environment. Their dedicated team of 8,000 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues in human and environmental health. Their innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain greater insights into their science to better protect their environment, their food supply and the health of their families.
Contact Phone:
Contact Email:
Listed Exchange:
NYSE
IPO Date:
1/13/1978
Ticker Symbol:
PKI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2022 | Virtue Diagnostics | Series B | 0 |
12/2020 | Carterra | Venture Round | 8.1M |
1/2022 | Virtue Diagnostics | Series B | 0 |
12/2020 | Carterra | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
7/2021 | BioLegend | |
6/2021 | SIRION BIOTECH | |
5/2021 | Immunodiagnostic Systems | |
5/2021 | Nexcelom Bioscience | |
1/2021 | Oxford Immunotec | |
11/2020 | Horizon Discovery | |
4/2019 | Cisbio.com | |
5/2018 | Shanghai Spectrum Instruments Co. Ltd. | |
2/2018 | RHS Ltd | |
6/2017 | EUROIMMUN AG |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|